| Literature DB >> 23677659 |
Abstract
Miller Fisher's syndrome is a rare variant of Guillain-Barré's syndrome characterized by the acute development of ataxia, ophthalmoparesis, and areflexia. Most patients have a measureable antibody in serum directed against the GQ1b ganglioside. This antibody is also present in the serum of patients with other forms of Guillain-Barré's syndrome who have prominent ataxia or ophthalmoplegia as part of their clinical presentation. Miller Fisher's syndrome generally is self-limited and has an excellent prognosis. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23677659 DOI: 10.1055/s-0033-1334470
Source DB: PubMed Journal: Semin Neurol ISSN: 0271-8235 Impact factor: 3.420